Dialysis Firm Sees ' Balanced ' Impact From GLP-1 Drugs Dialysis Firm Sees ' Balanced ' Impact From GLP-1 Drugs

The world ' s leading dialysis provider Fresenius Medical Care sees a ' balanced ' impact of the GLP-1 diabetes and weight-loss drugs on its patients.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news